tailieunhanh - Báo cáo y học: " Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học 'Respiratory Research cung cấp cho các bạn kiến thức về ngành y đề tài:"" Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. | Respiratory Research BioMed Central Research Efficacy of salmeterol fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease analysis from the randomised placebo-controlled TORCH study Christine R Jenkins 1 Paul W Jones 2 Peter MA Calverley 3 Bartolomé Celli 4 Julie A Anderson 5 Gary T Ferguson 6 Julie C Yates 7 Lisa R Willits 5 and Jorgen Vestbo 8 9 Open Access Address Woolcock Institute of Medical Research Sydney Australia 2Division of Cardiac and Vascular Science St George s University of London London UK 3University Hospital Liverpool UK 4St Elizabeth s Medical Centre Boston USA 5GlaxoSmithKline GSK Stockley Park UK 6Pulmonary Research Institute of Southeast Michigan Livonia USA 7GSK Research Triangle Park USA 8Wythenshawe Hospital Manchester UK and 9Hvidovre Hospital Hvidovre Denmark Email Christine R Jenkins - crj@ Paul W Jones - pjones@ Peter MA Calverley - pmacal@ Bartolome Celli - bcelli@ Julie A Anderson - GaryT Ferguson - garytferguson@ Julie C Yates Lisa JorgenVestbo-jvestbo@ Corresponding author fEqual contributors Published 30 June 2009 Received 29 May 2009 Respiratory Research 2009 10 59 doi 1465-9921-10-59 Accepted 30 June 2009 This article is available from http content 10 1 59 2009 Jenkins et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background The efficacy of inhaled salmeterol plus fluticasone propionate SFC in patients with severe or very severe COPD is well documented. However there are only limited data about the influence of GOLD severity staging on the effectiveness of SFC particularly in .